@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HGD6GZ6P-K skos:prefLabel "Antihistaminiques des récepteurs H1"@fr, "Histamine H1 Antagonists"@en ; a mesh:Descriptor, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-K576HN38-Q mesh:allowableQualifier jvr:-R3QWLHRG-V, jvr:-W6SQV79N-S, jvr:-G30ZJ446-J, jvr:-NHL3D2X0-S, jvr:-CB30NGKB-3, jvr:-NFTHND7Q-8, jvr:-S0CS1X5R-5, jvr:-L6C0XPHT-4, jvr:-D0F21513-5, jvr:-H7K65Q8S-Z, jvr:-T9HQD7ST-J, jvr:-G4R176S9-J, jvr:-THHNVC7V-3, jvr:-TJHVZCRZ-0, jvr:-M63HSDM7-1, jvr:-HQRFT0C6-B, jvr:-SBNWSM1T-R, jvr:-FWD2BGQ0-9, jvr:-R0ZCQ8X6-J, jvr:-XV06LPML-W, jvr:-NKM836P1-M, jvr:-WK5F724J-1, jvr:-BT300B3G-Q, jvr:-Q3979798-W, jvr:-NB0XHT3S-N ; skos:hiddenLabel "Cinnarizine, Dihydrochloride"@en, "Stugeron Forte"@en, "Cinazière"@en, "R-516"@fr, "R-516"@en, "Cinnarizin Von Ct"@en, "Cisaken"@en, "Cinarizina Ratiopharm"@en, "Cinnarizin Siegfried"@en, "R516"@fr, "Dichlorhydrate de cinnarizine"@fr, "Cinna"@en, "Cinarizina Inkey"@en, "Cinnarizine L-Tartrate (1:1)"@en, "Cinnarizine L-Tartrate"@en, "Cinnarizine, (E)-Isomer"@en, "Cinnarizin AL"@en, "Stugeron"@en, "Cinnipirine"@en, "Dimitronal"@en, "Cinnarizin-Ratiopharm"@en ; skos:altLabel "Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-"@fr, "Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-"@en, "7002-58-6 (di-HCl)"@en, "7002-58-6 (di-HCl)"@fr, "60145-68-8 (L-tartrate)"@en, "60145-68-8 (L-tartrate)"@fr, "Cinarizine"@en, "86349-62-4 (L-tartrate (1:1))"@fr, "86349-62-4 (L-tartrate (1:1))"@en, "298-57-7 (Cinnarizine)"@fr, "298-57-7 (Cinnarizine)"@en, "16699-20-0 ((E)-isomer)"@fr, "16699-20-0 ((E)-isomer)"@en, "1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine"@en, "3DI2E1X18L"@fr, "3DI2E1X18L"@en ; mesh:pharmacologicalAction jvr:-W8MNH2H7-8, jvr:-HGD6GZ6P-K ; skos:inScheme jvr: ; dc:modified "2017-05-24"^^xsd:date ; owl:sameAs ; skos:broader jvr:-ZSFBN4K6-W ; skos:definition "A piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS."@en ; a mesh:Descriptor, skos:Concept ; skos:prefLabel "Cinnarizine"@en, "Cinnarizine"@fr ; dc:created "1974-11-19"^^xsd:date ; dc:established "1986-01-01"^^xsd:date . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W8MNH2H7-8 skos:prefLabel "Inhibiteurs des canaux calciques"@fr, "Calcium Channel Blockers"@en ; a mesh:Descriptor, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-ZSFBN4K6-W skos:prefLabel "Piperazines"@en, "Pipérazines"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-K576HN38-Q . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .